Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
Implementing intervention mapping to tailor the evidence-based PREDIMED intervention for medically underserved prostate cancer patients.
Journal: Translational behavioral medicine
Published: June 08, 2026
Globalization of clinical trials: participation, development and future directions.
Journal: Current opinion in urology
Published: May 16, 2026
De Novo and Postradiation Adenocarcinoma of the Urethra: A Clinicopathologic and Radiologic Study of 55 Cases.
Journal: The American journal of surgical pathology
Published: May 15, 2026
Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time?
Journal: British journal of cancer
Published: May 07, 2026
Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer.
Journal: CA: a cancer journal for clinicians
Published: March 31, 2026
Multidisciplinary Care of Patients With Penile Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: March 17, 2026
European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.
Journal: European urology
Published: March 05, 2026
Determining Barriers to Dietary Change Among Medically Underserved Men With Prostate Cancer.
Journal: Health education & behavior : the official publication of the Society for Public Health Education
Published: February 25, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
Journal: The Journal of urology
Published: February 09, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
Journal: The Journal of urology
Published: February 09, 2026
Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma.
Journal: Future oncology (London, England)
Published: October 30, 2025
Last Updated: 09/26/2026